Clinical Trials Directory

Trials / Completed

CompletedNCT06532097

Initial Effect Size Estimation of a Smartwatch-based Intervention for Physical and Behavioral Activation in Depressed Patients

Initial Effect Size Estimation of a Smartwatch-based Intervention for Physical and Behavioral Activation in Depressed Patients: a Pilot-study

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
Max-Planck-Institute of Psychiatry · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

It is well known that physical activity interventions have a robust, if small-to-moderate effect on the amelioration of chronic diseases, including major depressive disorder (MDD) (Singh et al. 2023). At the same time, behavioral activation is one of the most effective components of digital cognitive-behavioral therapy for depression (Furakawa et al. 2021). Here we leveraged smartwatches to provide an interactive tool for delivering a mixed intervention of physical and behavioral activation, with the former addressing physical activity level and the latter pleasant activities including and beyond physical activity (e.g., social, relaxing activities). Moreover, given the relationship with physical activity level, we additionally incorporated digital insomnia exercises that have also shown promising effects in the amelioration of depression. Our primary aim was to estimate the effects of our digital smartwatch-based intervention in a small sample of depressed patients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical and behavioral smartwatch-based activationWe used smartwatches to provide an interactive tool for delivering a mixed intervention of physical and behavioral activation, with the former addressing physical activity level and the latter pleasant activities including and beyond physical activity (e.g., social, relaxing activities). Moreover, given the relationship with physical activity level, we additionally incorporated digital insomnia exercises that have also shown large effects in the amelioration of depression.

Timeline

Start date
2023-03-01
Primary completion
2024-01-31
Completion
2024-01-31
First posted
2024-08-01
Last updated
2024-11-21

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06532097. Inclusion in this directory is not an endorsement.